Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 1

Interventions

pembrolizumab 1281Specimen Handling 927Carboplatin 835Magnetic Resonance Spectroscopy 834Cyclophosphamide 809Cisplatin 733Nivolumab 683Paclitaxel 638Radiotherapy 614Gemcitabine 582Biopsy 558Bevacizumab 482Dexamethasone 446fludarabine 411Docetaxel 385venetoclax 371Oxaliplatin 368Capecitabine 364Fluorouracil 360atezolizumab 346durvalumab 340Rituximab 334Drug Therapy 332Doxorubicin 319Blood Specimen Collection 317Radiosurgery 317Standard of Care 311Pemetrexed 307Ipilimumab 306Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hand Strength × 1 year × Clear all
NCT05823740 2026-05-01

Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
28 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡